Allergan (AGN) CEO Says Not Focused on or Looking at Large Deals (BIIB)

August 8, 2016 9:21 AM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Allergan's (NYSE: AGN) CEO said the company isn't focused on or looking at large deals.

Traders are watching shares of rumored target Biogen (NASDAQ: BIIB) following the comments.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Management Comments, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment